The active ingredient in these drugs is Semaglutide
Review Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ, Diamant M, Joles JA, van Raalte DH (2016) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
PMID 24248213
As litigation unfolds and regulatory clarity emerges, stakeholders will need to stay informed and adaptable to responsibly meet patient needs in this rapidly changing therapeutic space
Compared with other psychiatric disorders, such as attention-deficit/hyperactivity disorder, ASD has many unanswered questions
Meredith said the capacity number varies, but he believes it's approximately 12 people to a shelter